5VM
5AM Venture Management Portfolio holdings
AUM
$260M
This Quarter Return
+10.91%
1 Year Return
+3.76%
3 Year Return
+144.87%
5 Year Return
+32.61%
10 Year Return
–
AUM
$492M
AUM Growth
+$492M
(+24%)
Cap. Flow
+$81.8M
Cap. Flow
% of AUM
16.61%
Top 10 Holdings %
Top 10 Hldgs %
91.13%
Holding
16
New
4
Increased
–
Reduced
3
Closed
–
Top Buys
| 1 |
Rallybio
RLYB
|
$73.7M |
| 2 |
Avidity Biosciences
RNA
|
$13.7M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$12.5M |
| 4 |
ARS Pharmaceuticals
SPRY
|
$1.69M |
Top Sells
| 1 |
IDEAYA Biosciences
IDYA
|
$10.2M |
| 2 |
Cabaletta Bio
CABA
|
$7.6M |
| 3 |
Cidara Therapeutics
CDTX
|
$1.95M |
Sector Composition
| 1 | Healthcare | 99.27% |
| 2 | Financials | 0.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vor Biopharma
VOR
$250M
| $105M | 21.31% | 6,692,429 | – | – |
|
|
2
Rallybio
RLYB
$22.4M
| $73.7M | 14.96% | +4,190,724 | New | +$73.7M |
|
|
AKUS
3
DELISTED
Akouos, Inc. Common Stock
AKUS
| $48M | 9.75% | 4,135,784 | – | – |
|
4
Q32 Bio
QTTB
$20.9M
| $35.7M | 7.25% | 4,535,919 | – | – |
|
|
5
IDEAYA Biosciences
IDYA
$2.15B
| $35.6M | 7.24% | 1,398,066 -400,000 | -22% | -$10.2M |
|
|
IMPL
6
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $35.1M | 7.13% | 2,884,791 | – | – |
|
7
Arvinas
ARVN
$568M
| $32.9M | 6.67% | 400,000 | – | – |
|
|
8
Cabaletta Bio
CABA
$133M
| $28.7M | 5.83% | 2,359,263 -625,000 | -21% | -$7.6M |
|
9
Crinetics Pharmaceuticals
CRNX
$2.92B
| $28.7M | 5.82% | 1,362,286 | – | – |
|
10
scPharmaceuticals
SCPH
$295M
| $25.5M | 5.17% | 3,831,474 | – | – |
|
|
11
Avidity Biosciences
RNA
$5.99B
| $13.7M | 2.78% | +555,555 | New | +$13.7M |
|
|
ISEE
12
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $12.5M | 2.54% | +770,000 | New | +$12.5M |
|
13
Janux Therapeutics
JANX
$1.37B
| $9.65M | 1.96% | 446,266 | – | – |
|
|
FVAM
14
DELISTED
5:01 Acquisition Corp. Class A Common Stock
FVAM
| $3.59M | 0.73% | 365,126 | – | – |
|
|
15
Cidara Therapeutics
CDTX
$1.66B
| $2.54M | 0.52% | 1,134,511 -872,000 | -43% | -$1.95M |
|
|
16
ARS Pharmaceuticals
SPRY
$1.15B
| $1.69M | 0.34% | +169,748 | New | +$1.69M |
|